These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16377407)

  • 1. Calcimimetics for predialysis patients?
    Fournier A; Shahapuni I; Harbouche L; Monge M
    Am J Kidney Dis; 2006 Jan; 47(1):196; author reply 196-7. PubMed ID: 16377407
    [No Abstract]   [Full Text] [Related]  

  • 2. Cinacalcet hydrochloride in chronic kidney disease-mineral bone disorder.
    Yokoyama K
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1405-8. PubMed ID: 19696214
    [No Abstract]   [Full Text] [Related]  

  • 3. Regression of parathyroid hyperplasia by calcimimetics--fact or illusion?
    Komaba H; Fukagawa M
    Nephrol Dial Transplant; 2009 Mar; 24(3):707-9. PubMed ID: 19103739
    [No Abstract]   [Full Text] [Related]  

  • 4. Cinacalcet cost and utility in dialysis patients.
    Cohen E; Uribarri J
    Semin Dial; 2005; 18(4):353-4. PubMed ID: 16076364
    [No Abstract]   [Full Text] [Related]  

  • 5. Fooling the parathyroid gland--will there be health benefits?
    Curhan G
    N Engl J Med; 2004 Apr; 350(15):1565-7. PubMed ID: 15071132
    [No Abstract]   [Full Text] [Related]  

  • 6. [Management of secondary hyperparathyroidism].
    Cunningham J
    Clin Calcium; 2005 Sep; 15 Suppl 1():217-24. PubMed ID: 16279027
    [No Abstract]   [Full Text] [Related]  

  • 7. Asymptomatic polyostotic Paget's disease associated with secondary hyperparathyroidism in a peritoneal dialysis patient.
    De Sousa-Amorim E; Del Peso-Gilsanz G; Bajo-Rubio MA; Selgas-Gutiérrez R
    Nefrologia; 2012 Jul; 32(4):542-4. PubMed ID: 22806296
    [No Abstract]   [Full Text] [Related]  

  • 8. Paricalcitol for treatment of secondary hyperparathyroidism in CKD patients.
    Drüeke TB; Landais P
    Am J Kidney Dis; 2006 Jun; 47(6):1083; author reply 1083-4. PubMed ID: 16731305
    [No Abstract]   [Full Text] [Related]  

  • 9. High dialysate calcium may improve the efficacy of calcimimetic treatment in hemodialysis patients with severe secondary hyperparathyroidism.
    Touam M; Menoyo V; Attaf D; Thebaud HE; Drüeke TB
    Kidney Int; 2005 May; 67(5):2065; author reply 2065-6. PubMed ID: 15840060
    [No Abstract]   [Full Text] [Related]  

  • 10. [Calcimimetics: physiology, results of preclinical and clinical studies, and perspectives].
    Torres PU
    Nephrol Ther; 2011 Apr; 7(2):99-104. PubMed ID: 21310676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of cinacalcet in the treatment of CKD-MBD].
    Koiwa F; Maruta Y
    Clin Calcium; 2010 Jul; 20(7):1089-95. PubMed ID: 20585188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinacalcet: benefit and cost.
    Cohen E
    Nephrol Dial Transplant; 2008 Apr; 23(4):1460; author reply 1460. PubMed ID: 18065795
    [No Abstract]   [Full Text] [Related]  

  • 13. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [German observational trial on secondary hyperparathyroidism therapy with cinacalcet (EARLY)].
    Reichel H; Braun J
    Dtsch Med Wochenschr; 2011 Jan; 136(4):123-8. PubMed ID: 21181622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does cinacalcet safely and effectively maintain long-term PTH control in secondary hyperparathyroidism?
    Fukagawa M
    Nat Clin Pract Nephrol; 2006 May; 2(5):248-9. PubMed ID: 16932435
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of cinacalcet for the treatment of secondary hyperparathyroidism in patients with advanced chronic kidney disease before initiation of regular dialysis.
    Montenegro J; Cornago I; Gallardo I; García-Ledesma P; Hernando A; Martinez I; Muñoz RI; Romero MA
    Nephrology (Carlton); 2012 Jan; 17(1):26-31. PubMed ID: 22022934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cinacalcet for secondary hyperparathyroidism in hemodialysis recipients.
    Owda AK; Alam MG; Kumar J
    N Engl J Med; 2004 Jul; 351(2):188-9; author reply 188-9. PubMed ID: 15247361
    [No Abstract]   [Full Text] [Related]  

  • 19. [Basic and clinical aspects of calcimimetics. The clinical effect and usefulness of Cinacalcet as a calcimimetics on three CKD-5D patients undergoing hemodialysis with refractory secondary hyperparathyroidism].
    Hanba Y; Ooura M; Negi S; Shigematsu T
    Clin Calcium; 2008 Jan; 18(1):81-8. PubMed ID: 18175876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of secondary hyperparathyroidism of dialysis patients with calcimimetics as a valuable addition to established therapeutic means.
    Drüeke TB
    Pediatr Nephrol; 2005 Mar; 20(3):399-403. PubMed ID: 15662538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.